Skip to main content

Becton Dickinson ownership: holders and insider trading

  • BDX · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$218.03+1.08%Close 13 Nov 2026 · Market value $59.20B

As filed, its directors and officers own 0.4% of the shares (proxy statement, 1 Dec 2025); 1,434 institutional managers reported holding 99.6% at 30 Jun 2026. Over the last twelve months, insiders sold $2.73M of shares on the open market, $2.12M of it under 10b5-1 plans set in advance, and bought none.

From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.

Largest holders

HolderTypeSharesOf the companySourceAs of
VanguardInstitution35.9M13.19%*Form 13F30 Jun 2026
First Eagle Investment Management, LLCInstitution27.6M10.14%*Form 13F30 Jun 2026
BlackRockInstitution24.6M9.03%*Form 13F30 Jun 2026
Vanguard Capital ManagementHolder21.4M7.51%Schedule 13G31 Mar 2026
Vanguard Portfolio ManagementHolder15.4M5.4%Schedule 13G31 Mar 2026
State StreetInstitution15.0M5.51%*Form 13F30 Jun 2026
InvescoInstitution8.9M3.27%*Form 13F30 Jun 2026
Massachusetts Financial Services CoInstitution8.7M3.18%*Form 13F30 Jun 2026
Geode Capital ManagementInstitution8.1M2.99%*Form 13F30 Jun 2026
T. Rowe PriceInstitution7.6M2.80%*Form 13F30 Jun 2026
Franklin TempletonInstitution7.0M2.57%*Form 13F30 Jun 2026
Wellington ManagementInstitution6.4M2.33%*Form 13F30 Jun 2026
Greenhaven Associates IncInstitution5.7M2.09%*Form 13F30 Jun 2026
Norges BankInstitution4.2M1.53%*Form 13F30 Jun 2026
American Century Companies IncInstitution3.7M1.35%*Form 13F30 Jun 2026
Charles SchwabInstitution3.4M1.25%*Form 13F30 Jun 2026
Morgan StanleyInstitution3.3M1.22%*Form 13F30 Jun 2026
Clearbridge Investments, LLCInstitution3.2M1.19%*Form 13F30 Jun 2026
Bank of AmericaInstitution3.1M1.15%*Form 13F30 Jun 2026
UBSInstitution3.0M1.10%*Form 13F30 Jun 2026

Insider transactions latest 25

InsiderDateTransactionSharesPriceValue
Feld Michael · EVP, Chief Revenue Officer28 Sep 2026Open-market sale (10b5-1 plan)−76$183.70$13.96K
Roque Vitor · EVP & Chief Financial Officer2 Sep 2026Shares withheld for tax−190——
Feld Michael · EVP, Chief Revenue Officer26 Aug 2026Open-market sale (10b5-1 plan)−165$188.49$31.10K
Feld Michael · EVP, Chief Revenue Officer20 Aug 2026Shares withheld for tax−1.0K——
Polen Thomas E Jr · Chairman, CEO and President · Director13 Aug 2026Open-market sale (10b5-1 plan)−4.2K$185.00$768.1K
Polen Thomas E Jr · Chairman, CEO and President · Director13 Aug 2026Option exercise+43.3K$167.25$7.24M
Goette Roland · EVP and President, EMEA11 Aug 2026Open-market sale−2.4K$180.84$440.9K
Feld Michael · EVP, Chief Revenue Officer27 Jul 2026Open-market sale (10b5-1 plan)−75$157.13$11.78K
Muhsin Bilal · EVP & President Connected Care2 Jul 2026Shares withheld for tax−1.9K——
Muhsin Bilal · EVP & President Connected Care1 Jul 2026Grant or award+14.3K——
Feld Michael · EVP, Chief Revenue Officer26 Jun 2026Open-market sale (10b5-1 plan)−75$152.80$11.46K
Garrison Michael David · EVP & Pres Med.Essntl&BioPharm24 Jun 2026Open-market sale (10b5-1 plan)−1.1K$145.66$160.2K
Garrison Michael David · EVP & Pres Med.Essntl&BioPharm10 Jun 2026Open-market sale (10b5-1 plan)−1.1K$151.48$166.6K
Polen Thomas E Jr · Chairman, CEO and President · Director1 Jun 2026Option exercise+20.2K$126.16$2.55M
Polen Thomas E Jr · Chairman, CEO and President · Director1 Jun 2026Open-market sale (10b5-1 plan)−2.8K$146.35$404.5K
Menziuso Peter · EVP and President, BDI1 Jun 2026Grant or award+14.3K——
Feld Michael · EVP, Chief Revenue Officer26 May 2026Open-market sale (10b5-1 plan)−75$147.35$11.05K
Roque Vitor · EVP & Chief Financial Officer7 May 2026Grant or award+1.7K——
Feld Michael · EVP, Chief Revenue Officer27 Apr 2026Open-market sale (10b5-1 plan)−74$151.94$11.24K
Neal Shana Carol · EVP and Chief People Officer6 Apr 2026Shares withheld for tax−1.1K——
Feld Michael · EVP, Chief Revenue Officer26 Mar 2026Open-market sale (10b5-1 plan)−75$156.83$11.76K
Minnix Lanesha · EVP and General Counsel16 Mar 2026Grant or award+7.5K——
Roque Vitor · Interim CFO2 Mar 2026Grant or award+931——
Spikner Pamela L. · SVP Controller & CAO2 Mar 2026Grant or award+931——
Feld Michael · EVP, Chief Revenue Officer26 Feb 2026Open-market sale (10b5-1 plan)−75$181.84$13.64K

Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.

BDX in the terminal

Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.